Dormant
VIAV · Viavi Solutions Inc.
Last analysed ·
Resolved Graded and closed 2026-07-10 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-13 and is not part of the scored record.
Current thesis
Networking-optical test theme still accelerating and the laggard test-and-measurement sleeve is finally re-rating: Susquehanna lifted its target to $66 (2026-07-01) and the small-cap-over-hyperscaler rotation flagged 2026-06-29 favors smaller infra names. But it's freshly diluted ($500M at $45, 2026-05-20) with no company event until the ~mid-August FQ4 print — a laggard-chase into a catalyst desert until it bases above the $45 offering shelf.
Kill line
A weekly close below $45.00 flags the diluted float failing to hold its May-2026 offering shelf. Secondary confirmation: NSE book-to-bill back under 1.0 on the ~mid-August FQ4 print, or the photonics leaders (LITE/COHR/EUV) rolling over on lower highs.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for VIAV —
As of 18 September 2026, the latest FrontierPicks analysis for Viavi Solutions Inc. (VIAV): Networking-optical test theme still accelerating and the laggard test-and-measurement sleeve is finally re-rating: Susquehanna lifted its target to $66 (2026-07-01) and the small-cap-over-hyperscaler rotation flagged 2026-06-29 favors smaller infra names. But it's freshly diluted ($500M at $45, 2026-05-20) with no company event until the ~mid-August FQ4 print — a laggard-chase into a catalyst desert until it bases above the $45 offering shelf.
Kill line: A weekly close below $45.00 flags the diluted float failing to hold its May-2026 offering shelf. Secondary confirmation: NSE book-to-bill back under 1.0 on the ~mid-August FQ4 print, or the photonics leaders (LITE/COHR/EUV) rolling over on lower highs.
Next dated event on file: — catalyst in 1d.
Current Thesis
Viavi Solutions’ AI-network testing growth supports a tentative recovery thesis: the next quarterly results must meet revenue guidance, and the shares must regain the May offering level before losing the September reference close. Success means a weekly close above $45.00 by the next results release, accompanied by quarterly revenue of at least $450 million; a weekly close below $34.50 invalidates the recovery case.
The September 11, 2026 adjusted close of $38.75 already breached the previous thesis’s $45.00 weekly invalidation threshold. That earlier case has failed. The narrower recovery case follows a company release dated September 12 announcing optical-network testing demonstrations at the September 21–23 European Conference on Optical Communication (ECOC). The announcement establishes product activity, without reporting associated orders or revenue. VIAVI announcement
As an inference, the narrative is maturing — the August 5 earnings report established the growth story, while the September 12 announcement extends the product catalogue and the September 11 close remains below the May offering price. The evidence does not establish expanding market participation.
Bullish and bearish views on Viavi Solutions Inc.
The model's bull view on Viavi Solutions Inc. (VIAV), in brief: Quarterly growth has financial evidence. The bear view: The previous threshold has failed. The September 11, 2026 adjusted close of $38.75 is below the $45.00 offering reference used in the previous published invalidation. The same price snapshot records a three-month decline of 27.5%. Acquisitions complicate growth comparisons. The… Both cases follow in full.
Bull Case
- Quarterly growth has financial evidence. VIAVI reported fiscal fourth-quarter revenue of $443.1 million, up 52.5% year over year, and adjusted diluted earnings per share of $0.34 on August 5, 2026. Company results
- Guidance provides a measurable test. On August 5, 2026, VIAVI forecast fiscal first-quarter revenue of $450–460 million and adjusted earnings per share of $0.40–0.42 for the period ending October 3. These are company forecasts, not reported results. Company outlook
- Product demonstrations extend testing coverage. The September 12, 2026 release names transceiver testing at 1.6 terabits per second and manufacturing tests for co-packaged optics and silicon photonics at ECOC. It supplies concrete product evidence for the network-testing thesis. VIAVI announcement
Bear Case
- The previous threshold has failed. The September 11, 2026 adjusted close of $38.75 is below the $45.00 offering reference used in the previous published invalidation. The same price snapshot records a three-month decline of 27.5%.
- Acquisitions complicate growth comparisons. The August 5, 2026 earnings disclosure attributed $47.7 million of fiscal fourth-quarter Network and Service Enablement revenue of $353.9 million to acquired Spirent product lines. The reported segment growth cannot be described as wholly organic.
- Recent ratings remain divided. MarketBeat records a September 8, 2026 Weiss Ratings downgrade to D from D+, following Rosenblatt’s August 19 reiteration of its $70 analyst target. These are third-party assessments, not evidence of subsequent operating performance. Dated ratings history
Setup & Price Structure
The September 11, 2026 adjusted-price snapshot places VIAV at $38.75, 30.0% below its reported 52-week high of $55.33. Its 14-period relative strength index is 49.6. Neither that indicator nor the supplied price observations establish a completed base.
The May 2026 offering price of $45.00 is the overhead reference for recovery. The September 2, 2026 published close of $34.50 provides the lower reference for this new thesis; it is an observed close, not a demonstrated support shelf. Moving-average levels, trading-volume participation and current short-interest measurements are missing, so distance above a rising average and squeeze pressure cannot be assessed.
The previously reported Form 4 summaries document director sales on August 14 and August 17, 2026, following an executive sale on August 10. This is a dated cluster of insider transactions. It does not establish their motives or support a conclusion about aggregate investor crowding.
Catalyst Calendar (next 30 days)
- 2026-09-21–2026-09-23 — ECOC demonstrations. VIAVI’s September 12 announcement commits to showcasing optical and AI-network testing products. The event tests delivery of the advertised demonstrations; attendance alone would not confirm the revenue thesis. Company announcement
- 2026-10-03 — Fiscal first-quarter end. This closes the period covered by the August 5 revenue guidance of $450–460 million. A quarter-end date is not a scheduled results disclosure. Company outlook
- ~2026-10-28, estimated — Fiscal first-quarter results. Beyond the next 30 days, MarketBeat estimates this reporting date; company confirmation remains missing. This replaces the earlier October 29 estimate and is the financial test on which the recovery thesis turns. Earnings calendar
What Would Change Our Mind
Loss of the September reference would break the recovery structure: a weekly close below $34.50 invalidates this thesis. Fiscal first-quarter revenue below the $450 million lower end of the August 5 guidance would independently break its operating premise.
Confirmation requires both financial delivery and price acceptance: revenue of at least $450 million and a weekly close above the May offering reference of $45.00 by the next results release. If the release arrives without that price condition, the recovery forecast has failed its stated horizon even if revenue meets guidance.
Correlation Notes
VIAVI’s September 12, 2026 product announcement connects its business to AI-network infrastructure, but that commercial connection does not measure equity correlation. This remains a single-name recovery thesis; the available dated observations are too few to support a claim that optical peers or hyperscaler shares reliably lead VIAV. Product exposure
Notes
- $500M equity offering priced 2026-05-20: 11,111,111 shares at $45.00 to repay Term Loan B; that price remains the overhead reference level.
- Fiscal year ends in late June (FY26 closed 2026-06-27) — headline "Q4" is the June quarter, and Q1 FY27 ends 2026-10-03.
- NSE growth is not clean organic: Spirent product lines contributed $47.7M of the $353.9M FQ4 NSE revenue; net that out for peer comparisons.
- GAAP and non-GAAP diverge widely — FY26 GAAP diluted EPS -$0.13 versus non-GAAP $1.00, largely Spirent amortization and integration cost.
- Elliott Management's activist position dates to October 2023 and remains a standing operating-margin overhang on the equity story.
- Optical Security & Performance ($89.2M in FQ4 FY26) is tied to consumer product cycles and anti-counterfeiting, not data-center test.
Related · shared themes
HPE
Hewlett Packard Enterprise Company
Hewlett Packard Enterprise's AI and networking earnings transition supports a repricing thesis that requires intact growth guidance and the first weekly close above $54.44 after the 2026-09-30 Investor Day. A weekly close below $50 invalidates the price thesis.
NTAP
NetApp, Inc.
NetApp's AI storage recovery requires delivery of September guidance before a weekly close below $164 breaks the thesis. Fiscal-Q2 revenue of at least $2.025 billion and non-GAAP gross margin of at least 67.0%, with the annual revenue outlook issued on 2026-09-02 maintained, would confirm the case.
XMTR
Xometry, Inc.
Xometry's AI manufacturing thesis requires enterprise adoption to deliver its August 4 guidance before a weekly close below $85. Third-quarter revenue of at least $234 million and adjusted EBITDA of at least $16 million, with the 33–34% full-year revenue-growth outlook maintained, would confirm the case.
DELL
Dell Technologies Inc.
Dell Technologies’ AI-server thesis requires roughly $19 billion of next-quarter revenue and infrastructure operating margin of at least 15.0%. The next quarterly results settle that case; September 21, 2026 index inclusion does not resolve the delivery or margin test.